Drug Shortage Report for JAMP ONDANSETRON
Report ID | 180280 |
Drug Identification Number | 02490617 |
Brand name | JAMP ONDANSETRON |
Common or Proper name | Ondansetron Oral Solution |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-09 |
Estimated end date | 2023-01-15 |
Actual end date | 2023-01-05 |
Shortage status | Resolved |
Updated date | 2023-01-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-01-10 | French | Compare |
v3 | 2023-01-10 | English | Compare |
v2 | 2023-01-09 | French | Compare |
v1 | 2023-01-09 | English | Compare |
Showing 1 to 4 of 4